CT scans track hip implant movement to predict Long-Term stability
NCT ID NCT07698717
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study tracks 30 people receiving a CATALYSTEM cementless hip implant to measure how much the stem moves (subsides) in the thigh bone over two years. Using specialized CT scans, researchers aim to see if the implant stays firmly in place, which is key for long-term success. Participants must have hip osteoarthritis and need a first-time total hip replacement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CATALYSTEM Cementless Primary Hip System
- What this could lead to
- If the implant shows stable positioning, it may support its use for long-lasting hip replacement outcomes.
- What could go wrong
- This is a small, early-stage imaging study, not a test of clinical benefits or risks. Results may not predict real-world performance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orthopaedic Innovation Centre
Winnipeg, Manitoba, R2K 2M9, Canada
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bowlegs and knee surgery: does preoperative alignment change pain outcomes?
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Could cord cell secretions ease arthritis pain?
- Which RA drug works best after the first one fails? a major trial aims to find out
- Custom knee surgery tools aim for better fit and faster recovery